Browse > Article

Screening of lovastatin-producing strains by PCR using lovastatin biosynthesis genes  

Ko, Hee-Sun (National Institute of Agricultural Science and Technology, RDA)
Kim, Hyun-Soo (Department of Microbiology, College of Natural Science, Keimyung University)
Publication Information
KSBB Journal / v.24, no.2, 2009 , pp. 163-169 More about this Journal
Abstract
Lovastatin (also known as Mevinolin, Mevacor, and Monacolin K), an inhibitor of the HMG-CoA reductase produced by Aspergillus terreus and other fungi, is used to reduce serum cholesterol levels in human beings. It is derived biosynthetically from two polyketides. One of these is a nonaketide that undergoes cyclization at a hexahydronaphthalene ring system, and the other is a simple diketide, 2-methylbutyrate. Two primer pairs were designed based on the amino acid sequences of lovastatin polyketide synthase and lovastatin diketide synthase for the PCR screening of lovastatin-producing strains. Among the seven selected strains, SJ-2 evidenced the highest level of lovastatin production in both liquid and solid cultures. Soybeans with SJ-2 were treated via 1 hour of heat shock at $30^{\circ}C$ for the mass production of lovastatin. The heat-treated soybeans were inoculated on rice bran and the koji extract was obtained after 15 days of incubation. It yielded the highest level of lovastatin production among the strains, and also evidenced 75% inhibition activity against HMG-CoA reductase. We developed an efficient PCR screening method for lovastatin-producing strains, using lovastatin biosynthesis genes.
Keywords
Aspergillus terreus; HMG-CoA reductase inhibitor; Lovastatin biosynthesis genes;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Tobert J. A. (1988), Efficacy and Long-term adverse effect pattern of lovastatin, J. American Cardiology. 62, 28-34
2 Serizawa, N., Nakagawa, K., Hamano, K., Tsujita, Y., Terahara, A., and Kuwano, H. (1983), Microbial hydroxylation of ML-236B (compactin) and monacolin K (MB-530B), J. Antibiot. 36, 604-607   DOI   PUBMED
3 Finkelstein D. B. and C. Ball (1992), Biotchnology of filamentous fungi, pp241-251, Butterworth-Heineman, London, U.K
4 Hutchinson C. R., J. Kennedy, C. Part, S. Kendrew, K. Auclair, and J. Vedras (2000), Aspect of the biosynthesis of non-aromatic fimgal polyketides by iterative polyketide synthases, Antonie Van Leewenhoek. 78, 287-295   DOI   ScienceOn
5 Kennedy J., K. Auclair, S. G. Kendrew, C. Park, J. S. Vederas, and C. R. Hutchinson (1999), Modulation of polyketide synthase activity by accessory proteins during lovastatin biosynthesis, Science 284, 1368-1372   DOI   PUBMED   ScienceOn
6 Lee J. W., S. M. Lee, K. S. Gwak, J. Y. Lee, and I. G. Choi (2006), Screening of edible mushrooms for the production of lovastatin and its HMG-CoA reductase inhibitory activity, Kor. J. Microbiol. 42, 83-88
7 Demain, A. L. (1999), Phannaceutically active secondary metabolites of microorganism, Appl. Microbiol. Biotechnol. 52, 455-463   DOI   PUBMED   ScienceOn
8 Hucher F. H. and W. H. Oleson (1973), Simplified spectrophotometrin for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A, J. Lipid Res. 14, 625-631   PUBMED
9 Moon Y. J., K. H. Yeum, and C. K. Sung (2000), Screening of 3-hydroxy-3 methylglutaryl- coenzyme A reductase inhibitor in vitro and its applicarion to pullets, Korean J. Food and Nutr. 15, 307-313
10 Slater E. E. and J. S. Macdonald (1988), Mechanism of action and biological profile of HMG-CoA reductase inhibitor, Drugs. 36, 72-82   DOI   PUBMED
11 Greenspan M. D. and J. B. Yudkorvitz (1985), Mevinolin acid biosynthesis by Aspergillus terreus and its relationship to fatty acid biosynthesis, J. Bacteriol. 162, 704-707   PUBMED
12 Hutchinson C. R and I. Fujii (1995), Polyketide synthase gene manipulation: a structure-function approach in engineering novel antibiotics, Annu. Rev. Microbiol. 49, 201-238   DOI   ScienceOn
13 Park J. H. and H. S. Kim (2004), Production of lovastatin in solid culture, J. Korean Soc. Food Sci. Nutr. 33, 566-570
14 Endo A. (1992), The discovery and development of HMG-CoA reductase inhibitors, J. Lipid Reseach. 33, 1569-1582
15 Albers A. W., J. Chen, G. Kuron, V. Hunt, C. Hoffman, J. Rothrock, M. Lopez, H. Joshua, E. Hairris, A. Patchett, R. Monaghan, S. Currie, E. Stapley, G. Alberts-Schonberg, O. Hensens, J. Hirshchfield, K. Hoogsteen, and J. Springer (1980), Mevinolin: a highly potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase and a cholesterollowing agent. Proc. Natl. Acad. Sci. 77, 3957-3961   DOI   ScienceOn
16 Hoffman, W. F., A. W. Alberts, P. S. Anderson, J. S. Chen, R. L. Smith, and A. K. Willard (1986), 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, 4 side chain ester derivatives of mevinolin, J. Med. Chem. 29, 849-852   DOI   PUBMED
17 Kumar M. S., P. M. Kimar, H. M. Sarnail, and A. K. Sadhukhan (2000), A rapid technique for screening of lovastatin-producing strains of Aspergillus terreus by agar plug and Neurospora crassa bioassay, Joumal of Microbiological Methods 40, 99-104   DOI   ScienceOn
18 Kinl S. J., H S. Ko, and H S. Kinl (2008), Development of seed culture using soybean for mass production of ;ovastatin with Aspergillus terreus ATCC 20542 mutant, J. Korean Soc. Food Sci. Nutr. 37, 666-670   DOI   ScienceOn
19 Stryer, L. (1995), In Biochemistry, W. H. Freeman & Company, New York. Vol. 4, pp685-712